Rydex Biotechnology Fund - C Class (RYCFX) Forecast
See the Price Targets and Ratings of:
RYCFX Analyst Rating
Strong Buy
70ConsensusRatings
63Buy7Hold0Sell
Based on the Wall Street analyst consensus for 70 of RYCFX’s holdings.
RYCFX Analyst Price Target
Average Price Target
$73.88▲(31.43% Upside)
Based on Wall Street analyst 12-month price targets for 70 of Rydex Biotechnology Fund - C Class’s holdings in the last 3 months. The average price target is $73.88 with a high forecast of $93.57 and a low forecast of $53.05. The average price target represents a 31.43% change from the last price of $56.21.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$93.57
Average$73.88
Low$53.05
Past 12 Months12 Month Forecast$42$55$68$81$94Feb2026May2026Aug2026Nov2026Nov2027
What is RYCFX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 70 of RYCFX’s holdings, Rydex Biotechnology Fund - C Class’s 12-month average price target is $73.88.
What is RYCFX’s upside potential, based on the analysts’ average price target?
RYCFX’s average price target of $73.88 represents a 31.43% upside from its last price of $56.21.
Is RYCFX a Buy, Sell or Hold?
Rydex Biotechnology Fund - C Class has a consensus rating of Strong Buy, based on the analyst consensus for 70 of RYCFX’s holdings: 63 rated Buy, 7 rated Hold and 0 rated Sell.
What is Rydex Biotechnology Fund - C Class’s price target?
The average price target for Rydex Biotechnology Fund - C Class is $73.88, based on Wall Street analyst 12-month price targets for 70 of RYCFX’s holdings, issued in the past 3 months. The highest price target is $93.57 and the lowest is $53.05. The average price target represents a 31.43% increase from the last price of $56.21.
How can I buy shares of RYCFX?
You can buy shares of RYCFX through a brokerage account. Compare brokers on our Best Online Brokers page.